Background-Reactive oxygen species serve signaling functions in the vasculature, and hypoxia has been associated with increased reactive oxygen species production. NADPH oxidase 4 (Nox4) is a reactive oxygen species-producing enzyme that is highly expressed in the endothelium, yet its specific role is unknown. We sought to determine the role of Nox4 in the endothelial response to hypoxia. Methods and Results-Hypoxia induced Nox4 expression both in vitro and in vivo and overexpression of Nox4 was sufficient to promote endothelial proliferation, migration, and tube formation. To determine the in vivo relevance of our observations, we generated transgenic mice with endothelial-specific Nox4 overexpression using the vascular endothelial cadherin promoter (VECad-Nox4 mice). In vivo, the VECad-Nox4 mice had accelerated recovery from hindlimb ischemia and enhanced aortic capillary sprouting. Because endothelial nitric oxide synthase (eNOS) is involved in endothelial angiogenic responses and eNOS is activated by reactive oxygen species, we probed the effect of Nox4 on eNOS. In cultured endothelial cells overexpressing Nox4, we observed a significant increase in eNOS protein expression and activity. To causally address the link between eNOS and Nox4, we crossed our transgenic Nox4 mice with eNOS Ϫ/Ϫ mice. Aortas from these mice did not demonstrate enhanced aortic sprouting, and VECad-Nox4 mice on the eNOS Ϫ/Ϫ background did not demonstrate enhanced recovery from hindlimb ischemia. Conclusions-Collectively, we demonstrate that augmented endothelial Nox4 expression promotes angiogenesis and recovery from hypoxia in an eNOS-dependent manner. (Circulation. 2011;124:731-740.)
R eactive oxygen species (ROS) such as superoxide anion and hydrogen peroxide (H 2 O 2 ) have been linked to the onset and progression of cardiovascular disease, yet antioxidant strategies to reduce ROS levels have failed to limit cardiovascular events. 1 Thus, ROS levels alone are not a determinant of pathology, suggesting that the role of ROS in disease processes is complex. One reason that ROS may have unpredictable consequences in the vasculature is that they also serve as second messengers in multiple cellular processes such as proliferation, differentiation, and apoptosis. 2 In addition, ROS are important for cytoskeletal rearrangement and cell migration in response to angiogenesis-inducing growth factors, including vascular endothelial growth factor (VEGF) 3, 4 and angiopoietin-1. 5 Thus, there is evidence that ROS are involved in vascular physiology.
Clinical Perspective on p 740
Tissue ischemia and the resultant hypoxia initiate a tightly regulated response that includes both cellular adaptation and efforts to improve oxygen delivery, such as angiogenesis. Evidence now indicates that the response to hypoxia is dependent, in part, on ROS production. For example, the upregulation of VEGF and VEGF receptors is linked to a concomitant increase in ROS production during hypoxia. 6 Ligand engagement of the VEGF receptor results in ROS production, 7 and exogenous application of ROS promotes endothelial responses that mimic angiogenesis such as increased cell proliferation, migration, and tube formation. 8 The specificity of hypoxiainducible factor-1␣, the master regulator of hypoxia-induced genes, is derived from protein stabilization due to an ROS flux during hypoxia, which is absent in anoxia. 9, 10 Thus, ROS are clearly involved in signaling responses important for angiogenesis. However, the specific ROS sources that mediate these physiological events are not completely defined.
Many members of the NADPH oxidase (Nox) enzyme family are expressed in the vasculature and produce ROS in response to environmental cues. In general, these enzymes are governed by the requirement for accessory proteins that facilitate full enzyme activity via the transfer of NADPHderived electrons to molecular oxygen, initially resulting in superoxide formation. 11 Among the Nox family, the Nox4 isoform is unique in that it requires little regulation from accessory proteins and primarily releases H 2 O 2 into the cytosol. [12] [13] [14] [15] Multiple lines of evidence suggest that Nox4 is involved in the adaptation to hypoxia as it is upregulated in tissue ischemia, 16 -19 and Nox4 inhibition prevents endothelialderived tumor formation. 20 The vascular endothelium contains abundant Nox4, 21, 22 and this oxidase mediates endothelial responses to transforming growth factor-␤ 23 and epidermal growth factor, 24 which include migration and proliferation. Despite these data linking Nox4 to hypoxic responses, its specific role is not yet known, and therefore we sought to identify the implications of endothelial Nox4 in the adaptation to hypoxia.
Methods

Cell Culture
Cultured human and bovine endothelial cells (ECs) were obtained from Lonza (Basel, Switzerland) and used between passages 3 and 8. Human cells were cultured in endothelial growth medium-2 containing 2% fetal bovine serum, and bovine cells were cultured in endothelial growth medium with 5% fetal bovine serum with the included bullet kit supplements (Lonza). Mouse lung ECs were harvested via 2 consecutive selections with the use of intercellular adhesion molecule-2 and cultured on 0.2% gelatin-coated dishes in endothelial growth medium-2 containing 10% fetal bovine serum. The cells were used for experiments between passages 2 and 6.
Adenoviral Constructs
The adenoviral vector expressing Nox4 was a gift from Dr Barry Goldstein (Thomas Jefferson University). 25 The adenoviral vector expressing Nox4 RNA interference (Nox4i) was constructed as described in Chen et al. 24 Cells were typically infected at a multiplicity of infection of 10 to 50 with a control adenovirus at the same multiplicity of infection. For in vivo administration of adenovirus, 3 days before surgery, either LacZ or Nox4 adenoviral constructs (2ϫ10 8 plaque-forming units) were injected into 5 sites of the thigh adductor muscle.
Polymerase Chain Reaction
Total RNA was extracted with the use of Qiagen RNeasy Mini Kits for cells and with the use of TRIzol (Invitrogen) for tissue samples according to the manufacturer's protocol. Total RNA was reversetranscribed to cDNA with the use of Qiagen Omniscript RT Kit at 37°C for 60 minutes. The primers used for polymerase chain reaction were as follows: Nox4 forward: tacctccgaggatcacagaa; Nox4 reverse: gaatctgggctcttccatac; Nox2 forward: tgcgtgctgctcaacaagag; Nox2 reverse: ggagggtttccagcaaactg; Nox1 forward: gcgtctgctctctgctttaa; Nox1 reverse: agcaacgctggtgaatgtca; GAPDH forward: acagtccatgccatcactgcc; GAPDH reverse: aggaaatgagcttgacaaagt; 18S forward: cggctaccacatccaaggaa; 18S reverse: gctggaattaccgcggct. The realtime polymerase chain reaction primers used were as follows: human Nox4 forward: cagaaggttccaagcaggag; human Nox4 reverse: gttgagggcattcaccagat; GAPDH forward: acccagaagactgtggatgg; GAPDH reverse: aggccatgccagtgagctt. For mouse muscle Nox4 expression, the primers were as follows: mouse Nox4 forward: acttttcattgggcgtcctc; mouse Nox4 reverse: agaactgggtccacagcaga. The signal was normalized to mouse HPRT1 forward: tggccatctgcctagtaaagc; and HPRT1 reverse: ggctcatagtgcaaatcaaaagtc. The realtime polymerase chain reaction reactions were run on a Bio-RAD iQ5 iCycler.
Determination of Reactive Oxygen Species
As an index of ROS generation, we used the Amplex Ultra Red reagent 10-acetyl-3,7-dihydroxyphenoxazine (Molecular Probes; A36006), which reacts with hydrogen peroxide (1:1 stoichiometry) in the presence of horseradish peroxidase to form resorufin. ECs were cultured to confluence in 12-well plates and incubated with Krebs' HEPES buffer (mmol/L: NaCl 118, HEPES 22, KCl 4.6, MgSO 4 2.1, Na 2 HPO 4 0.15, KH 2 PO 4 0.41, NaHCO 3 5, glucose 5.6, CaCl 2 1.5) for 30 minutes. The Amplex Ultra Red and horseradish peroxidase were then added, and fluorescence (excitation 544 nm; emission 590 nm) was determined as a function of time (2 hours) in 96-well black plates (Corning) at 37°C in a fluorescent plate reader (Spectramax, Molecular Devices).
Endothelial Tube Formation and Migration
We utilized the spontaneous organization of ECs into capillary-like tubules when grown in vitro on Matrigel. Cells were cultured alone or with adenoviral constructs for 24 hours. Cells were then trypsinized and plated on Matrigel and monitored over time (6 to 12 hours) for tube formation as described. At least 5 random fields of vision were then analyzed for tube length with the use of NIH Image J software for quantification. For migration, we utilized the scratch assay. Bovine aortic ECs (Lonza) were infected with LacZ, Nox4, or Nox4i adenovirus for 48 hours. Cells were then treated with 50 g/mL mitomycin C to inhibit proliferation and scratched with a 200-L pipet. Migration was quantified as the extent of gap closure with NIH Image J software.
Generation of Endothelial-Specific Nox4 Transgenic Mice
Full-length human Nox4 cDNA was subcloned into the pCR3.1 vector (Invitrogen) followed by restriction digestion with KpnI and XhoI. The resultant fragment was inserted into the NotI site between the mouse vascular endothelial cadherin (VE-Cad) promoter and the SV40 polyadenylation sequence of the pBSmVE vector, 26 and the resultant construct was confirmed by sequencing. A linearized DNA fragment containing the intact mouse VE-Cad promoter-human Nox4 -SV40pA cassette was used for pronuclear injection to generate multiple founders with endothelial-specific expression of human Nox4 in the C57/Bl6 background (University of Massachusetts Transgenic Core Facility). The primers used for genotyping are as follows: 5Ј-cta tct gca ggc agc tca ca-3Ј and 5Ј-gat gaa cag gca gag gtg tt-3Ј.
In Situ Hybridization
To detect human Nox4 expression specifically, a 750-bp probe was designed that contained 530 bp of the human Nox4 sequence and 220 bp of the VE-Cad vector. The fragment was cloned into pBluescript SK (Stratagene), and riboprobes were synthesized following the digoxigenin labeling manufacturer's protocol (Roche). Slides (14-m cryosection) were incubated with probe overnight at 50°C and blocked with maleic acid butter with Tween 20/2% blocking reagent (Roche)/20% sheep serum at room temperature for 2 to 3 hours; anti-digoxigenin alkaline phosphatase was then added to the slides (1:3000 dilution), followed by incubation overnight at 4°C. Slides were then stained with 5-bromo-4-chloro-3-indolyl phosphate/nitro-blue (3.5 L/mL) overnight at 37°C, and images were obtained with a 40ϫ1.30 objective (Nikon) on an inverted microscope (TE-2000; Nikon) with a camera (Cool-SNAP HQ; Photometrics). Images were captured with the use of NIS Elements software (Nikon).
Immunofluorescence
Aortas were perfused with 4 mL of 0.9% sterile saline solution before excision and removal of perivascular fat and adventitia with the use of a dissecting microscope. Tissue was then formalin-fixed for 12 hours, and paraffin was embedded. Nox4 antibody (Novus) was diluted 1:50, and von Willebrand factor was diluted 1:100 (abcam). Secondary antibodies (Fluor488-or Fluor594-tagged goat anti-rabbit or donkey anti-sheep IgG; Invitrogen) were diluted 1:200.
Fluorescence images were obtained with the use of a 20ϫ1.30 objective on the inverted aforementioned microscope system.
Capillary Sprouting
The aortas were perfused and cleaned as described above, then 1-mm segments were placed in 300 L cold Matrigel in a 48-well plate. After 30 minutes in a 37°C incubator, endothelial basal medium-2/ 10% fetal bovine serum was added, and the medium was changed every other day. Capillary sprouting was counted by phase-contrast microscopy with the use of at least 6 segments of aorta from 4 mice per group. Aortic ring sprouts were analyzed carefully on the basis of morphological differences in growth between the endothelial sprouts and fibroblast sprouts based on greater thickness and a uniform pattern of growth. Sprout counting was confirmed with CD31 staining (data not shown).
Hindlimb Ischemia and Laser Doppler Imaging
Animals were anesthetized with ketamine (100 mg/kg) and xylazine (20 mg/kg) via intraperitoneal injection and placed on a heated water blanket to maintain body temperature. The left femoral artery was exposed via an inguinal incision (1.5 to 2 cm), and the femoral artery was ligated and removed from its origin to the proximal portion of the saphenous artery (along with the adjacent veins). For eNOS Ϫ/Ϫ animals, the femoral artery and vein were simply ligated (5.0 nylon suture) at the origin to prevent limb loss. 27 Animals underwent periodic assessment of blood flow with laser Doppler imaging (a noninvasive technique that allows a user to monitor how the perfusion gradually recovers over time) as described. 28 
Immunohistochemistry
Ischemic and nonischemic muscle was removed and immediately frozen in Tissue Tek OCT, and sections (7 mol/L) were subsequently stained with antibody to platelet EC adhesion molecule-1 (CD31; BD Pharmingen) and counterstained with hematoxylin and eosin. Cells positive for CD31 antigen were counted by phasecontrast microscopy with at least 4 different microscopic fields from each animal, and capillary density was expressed as the capillary number/muscle fiber (ϫ40) or as normalized to nonischemic capillary density per field of vision (ϫ20). Images were obtained with the use of the aforementioned inverted microscope system.
Isometric Measurements of Endothelial Function
Thoracic aortic rings (2 mm in length) were mounted on 200-mol/L pins in a 6-mL vessel myograph (Danish Myo Technology) containing physiological salt solution (mmol/L: NaCl 130, KCl 4.7, KHPO 4 1.18, MgSO 4 1.17, CaCl 2 1.6, NaHCO 3 14.9, dextrose 5.5, CaNa 2 / EDTA 0.03). Vessels were stretched to 1-g basal tension at 37°C and aerated with 95% O 2 /5% CO 2 . Vessels were equilibrated in physiological salt solution for 1 hour, followed by 2 consecutive contractions with physiological salt solution containing 60 mmol/L potassium and 1 mol/L phenylephrine, then with physiological salt solution containing 60 mmol/L potassium alone. Rings were then washed, allowed to return to basal tension, and subjected to concentration-response curves to phenylephrine.
cGMP Measurement
To measure cGMP in vitro, we cultured human aortic ECs with and without adenoviral constructs and rat aortic smooth muscle cells to confluence in 6-well plates. Cells were then washed twice with Locke's buffer (mmol/L: NaCl 154, KCl 5.6, CaCl 2 2, MgCl 2 1, HEPES 10; pH 7.4) and allowed to equilibrate in Locke's buffer containing 200 mol/L 3-isobutyl-1-methylxanthine (IBMX), 100 U/mL superoxide dismutase, and 200 mol/L L-arginine for 30 minutes. The calcium ionophore (A23187; 10 mol/L; Sigma) was then added to the stimulated wells of the human aortic ECs for 30 minutes. The endothelial bathing medium was transferred immediately to the rat aortic smooth muscle cells for 3 minutes. The reaction was stopped with the immediate removal of buffer and addition of ice-cold 5% trichloroacetic acid. cGMP was measured with the use of commercial enzyme-linked immunosorbent assay kits according to the manufacturer's instructions (Cayman Chemicals, Ann Arbor, MI). Results are expressed as normalized to the adenoviral untreated control of 3 separate experiments run in triplicate.
To measure tissue cGMP, aortas were removed and cleared of connective tissue as described above. Aortic rings 2 mm in width were cut and placed into individual wells of a 96-well plate with 100 L of Dulbecco's modified Eagle's medium with 10% fetal bovine serum and 500 mol/L IBMX plus 200 mol/L L-arginine. Aortic rings were allowed to equilibrate for 30 minutes, and then fresh medium was added with or without 500 mol/L N G -nitro-L-arginine methyl ester and incubated for 20 minutes. Aortas were then snap-frozen in liquid nitrogen and immediately placed in ice-cold 0.1 mol/L HCl and homogenized. Samples were diluted 1:3, and cGMP was measured with a commercial enzyme-linked immunosorbent assay kit according to the manufacturer's instructions (Cayman Chemicals, Ann Arbor, MI). At least 3 segments in each condition from 4 mice per group were measured.
Statistical Analysis
All data are presented as meanϮSEM. Images shown are representative of Ն3 independent experiments. Comparisons among 2 treatment groups were performed with a Student t test, and comparisons among Ն3 groups involved 1-way ANOVA with a post hoc Dunnett comparison. Dose-response curves were compared with 2-way ANOVA with or without repeated measures as appropriate. Statistical significance was accepted if the null hypothesis was rejected with PϽ0.05. 
Results
Hypoxia Upregulates Nox4
To examine whether Nox4 regulation is a part of the cellular hypoxic response, cultured ECs were subjected to hypoxia (1% oxygen), and we observed a marked increase in Nox4 mRNA and protein expression coincident with hypoxiainducible factor-1␣ upregulation ( Figure 1A and 1B) . We did not see increased expression of other Nox isoforms ( Figure  IA in the online-only Data Supplement). We then probed the in vivo relevance of these observations in wild-type C57/Bl6 mice with hindlimb ischemia and found increased Nox4 expression in ischemic gastrocnemius (5-fold) and thigh adductor muscles (2-fold) compared with nonischemic muscle ( Figure 1C; PϽ0.05; nϭ4) . Thus, hypoxia is associated with Nox4 upregulation in vitro and in vivo.
Nox4 Stimulates Angiogenesis
Previously, we have shown that Nox4 overexpression potentiates endothelial proliferation. 24 To determine whether Nox4 also drives EC behaviors important for angiogenesis, we overexpressed or knocked down Nox4 using Nox4 and Nox4i adenovirus in ECs ( Figure IB to ID in the online-only Data Supplement) under conditions that do not affect Nox2 expression ( Figure IB in the online-only Data Supplement) and examined EC tube formation and migration. Under basal conditions, increasing Nox4 expression alone increased endothelial tube formation ( Figure 2A ) and migration ( Figure  2B ). Conversely, with knockdown of Nox4, we observed blunted tube formation ( Figure 2C ) and migration ( Figure  2D ). To examine the role of ROS in Nox4-mediated tube formation, we overexpressed Nox4 in ECs and found that the antioxidants taxifolin (250 mol/L) and polyethylene glycol/ catalase (200 U/mL) decreased Nox4-induced tube formation ( Figure 2E ). Thus, Nox4 promotes angiogenesis in a ROSdependent manner. We then probed the in vivo consequences of acute Nox4 overexpression utilizing a hindlimb ischemia-induced angiogenesis model. 28 We observed enhanced blood flow recovery in mice receiving local adenoviral Nox4 injection compared with LacZ injection (Figure 3A and 3B) . Blood flow recovery reflected increased capillary density determined by CD31 staining of muscle tissue ( Figure 3C and 3D) . Thus, these data support the notion that Nox4 stimulates angiogenesis.
Generation of Endothelial-Specific Nox4 Transgenic Mice
To determine whether endothelial Nox4 expression is sufficient to stimulate angiogenesis, we created transgenic mice harboring the human Nox4 gene under control of the VE-Cad promoter (VE-Cad-Nox4; Figure 4A ). Mouse lung ECs were harvested from wild-type and multiple transgenic animals that exhibited increased Nox4 mRNA ( Figure 4B ) and protein ( Figure 4C ). We then assayed ROS production in mouse lung ECs from 2 lines of transgenic animals versus control mice and observed a 20% to 30% increase in hydrogen peroxide production as assessed by Amplex Ultra Red reagent ( Figure  4D ). In aortic sections from wild-type and VE-Cad-Nox4 mice, we observed increased Nox4 mRNA ( Figure 4E ) and protein ( Figure 4F ) expression. We then removed the endothelium from the aorta (detergent perfusion), which is a small percentage of the total aortic tissue, and compared this with lung (highly endothelialized) tissue from the same mice and demonstrated clear mRNA overexpression in the transgenic lung tissue, which was not seen in the deendothelialized aorta ( Figure IIA in the online-only Data Supplement). We also assessed lung tissue expression in both young (3 months) and old mice (1 year) and found sustained increased expression at both the mRNA and protein levels ( Figure IIB and IIC in the online-only Data Supplement).
Endothelial Nox4 Is Sufficient to Promote Angiogenesis
We probed capillary sprouting from intact aorta as a model of early angiogenesis. Aorta from VE-Cad-Nox4 mice demonstrated enhanced ex vivo capillary sprouting compared with wild-type littermates ( Figure 5A ). To evaluate the physiological relevance of this observation, we utilized the hindlimb ischemia model and found that blood flow recovery after femoral artery excision was significantly hastened in VE-Cad-Nox4 mice compared with littermate controls ( Figure  5B ). Consistent with increased angiogenesis, there was increased capillary density in gastrocnemius muscle harvested from VE-Cad-Nox4 compared with wild-type animals (Figure 5C and 5D ).
Nox4 Increases Endothelial Nitric Oxide Synthase Activity and Expression
Endothelial nitric oxide synthase (eNOS) is a key regulator of angiogenesis, 29 and there is evidence that ROS may regulate ). E, Segments of wild-type and Nox4 transgenic aortas were isolated, fixed, and assessed for Nox4 gene expression with the use of in situ hybridization (ϫ40). E indicates the endothelium. F, Aortic segments from wild-type and transgenic mice were fixed and paraffin embedded and costained with von Willebrand factor (VWF), an endothelial marker, and Nox4 for immunofluorescence (ϫ20).
eNOS expression and activity. 30, 31 Therefore, we probed eNOS regulation by Nox4. In cultured ECs, Nox4 overexpression produced increased total eNOS expression and activity ( Figure 6A ). To further assess Nox4 activation of eNOS, we measured cGMP accumulation in a coculture system using human aortic ECs and rat aortic smooth muscle cells. Under basal conditions, we saw a 2-fold increase in cGMP production, which was increased dramatically on stimulation with the calcium ionophore A23187 ( Figure 6B) . To further probe the mechanisms of eNOS regulation by Nox4, we introduced catalase into our Nox4 overexpression system and observed an attenuation of both expression and phosphorylation of eNOS ( Figure 6C ), indicating that Nox4derived ROS were responsible for eNOS activation. Under hypoxic conditions, adenoviral knockdown of Nox4 led to a decrease of both total and Ser-1177 phosphorylated eNOS ( Figure 6D) . Consistent with the observation that Nox4 enhances eNOS activity, aorta from VE-Cad-Nox4 transgenic mice demonstrated increased basal NO ⅐ production manifest as enhanced cGMP production ( Figure 6E ). This increase in basal eNOS activity appeared functional because intact aortic rings from VE-Cad-Nox4 mice exhibited less phenylephrine-induced contraction than vessels from littermate controls ( Figure 6F ). To further examine the role of basal NO ⅐ bioactivity, we conducted functional aortic assays on VE-Cad-Nox4 transgenic mice bred onto the eNOS-null (eNOS Ϫ/Ϫ ) background and found no effect of Nox4 in the absence of eNOS ( Figure 6G ).
Nox4 Stimulation of Angiogenesis Requires Endothelial Nitric Oxide Synthase
To test the hypothesis that eNOS activation is required for Nox4 stimulation of angiogenesis in vivo, we utilized the VE-Cad-Nox4 transgenic mice on the eNOS Ϫ/Ϫ background. In aorta from mice lacking eNOS, there was no difference in capillary sprouting as a function of the transgene ( Figure 7A ). Moreover, endothelial Nox4 overexpression no longer accel-erated the recovery from hindlimb ischemia in mice lacking eNOS ( Figure 7B and 7C) . Collectively, these data demonstrate that Nox4 stimulation of angiogenesis requires eNOS ( Figure 7D ).
Discussion
Our data demonstrate that hypoxia is associated with upregulation of Nox4 and that endothelial Nox4 is sufficient to promote angiogenesis in an eNOS-dependent manner. In cultured ECs and in vivo, hypoxia was associated with robust upregulation of Nox4, suggesting that Nox4 upregulation may be an adaptive response to tissue ischemia and hypoxia. The endothelium responds to ischemia by promoting angiogenesis, and in the present study we demonstrate that endothelial Nox4 upregulation was sufficient to promote many salient features of the angiogenic process. Specifically, endothelial proliferation, migration, and tube formation were promoted by Nox4 in a ROS-dependent manner. Importantly, these findings were physiologically relevant because Nox4 overexpression in vivo led to enhanced angiogenesis in response to hypoxia. The vascular EC appeared central in mediating this effect because endothelial-specific Nox4 overexpression promoted angiogenesis both in vitro and in vivo. Finally, we were able to demonstrate that the mechanism whereby Nox4 promotes angiogenesis was eNOS dependent, mediated by H 2 O 2 . Thus, our data implicate Nox4 as an important adaptive response to ischemia that coordinates the endothelial contribution to new vessel formation.
Data in the literature have demonstrated that Nox4 is upregulated in hypoxic settings such as ischemia and tumor angiogenesis. Ischemic brain injury is associated with an upregulation of Nox4 expression that corresponds temporally to the initiation of angiogenesis. 18 These data, coupled with the fact that Nox4 expression is increased in newly formed capillaries, suggest that Nox4 is linked to angiogenesis. Moreover, hypoxia-induced tumor angiogenesis is associated with Nox4 upregulation, 32, 33 and Nox4 suppression in ovarian cancer cells limits angiogenesis. 32 Our data demonstrate a causal role for endothelial Nox4 in promoting angiogenesis because Nox4 overexpression is sufficient to promote key endothelial phenotypes (eg, proliferation, migration, tube formation), and Nox4 knockdown hinders these processes that are important in new vessel formation. These findings are of physiological relevance because we found that mice with endothelial-specific Nox4 overexpression exhibited significant promotion of blood flow recovery in response to hindlimb ischemia. In multiple ischemia/reperfusion studies, excessive ROS production is known to cause tissue damage. However, in this study we observed a beneficial response with overexpression of a ROS-producing enzyme after hypoxia. The manner in which Nox4 promotes tissue repair rather than injury is not yet clear but is likely related to the unique characteristics of the enzyme. For example, Nox4 releases H 2 O 2 , [12] [13] [14] [15] and this species is a 2-electron oxidant well suited for cell signaling owing to its preferred target (thiols) and relatively longer half-life compared with other ROS such as superoxide. 34 Moreover, Nox4 seems to generate ROS constitutively rather than producing a high-level burst as in the neutrophil enzyme Nox2. It is therefore plausible that Nox4-derived ROS are not cytotoxic and, as a consequence, are involved in mediating reparative signaling.
Our data identify eNOS as a downstream component of Nox4 signaling. eNOS and its production of bioactive NO ⅐ contribute to angiogenesis 35 through enhancing EC proliferation and migration. 36, 37 As a consequence, mice lacking eNOS exhibit a significant impairment in ischemia-induced angiogenesis. 27 Given that pathological increases in vascular ROS are known to limit NO ⅐ bioactivity, 38 it is surprising that a ROS-producing enzyme promotes an NO ⅐ -dependent process. However, evidence in the literature helps to reconcile these seemingly contradictory results because one particular ROS, H 2 O 2 , is known to both activate eNOS and upregulate its transcription. 30, 31, 39 Consistent with these published data, we observed increased eNOS expression and activity in ECs overexpressing Nox4, which was reduced in the presence of the H 2 O 2 scavenger catalase. In hypoxia, we found Nox4 upregulation that coincided with eNOS phosphorylation, whereas Nox4 RNAi limited the phosphorylation of eNOS. Collectively, these data imply a physiological role for Nox4 in mediating the endothelial response to hypoxia.
The data presented here also generally agree with a recent report 40 demonstrating that Nox5, a calcium-dependent Nox isoform, enhances eNOS catalytic activity in both cultured endothelium and mouse aorta. Despite this increase in eNOS catalytic activity, Zhang and colleagues 40 observed reduced NO ⅐ bioactivity suggesting extracellular consumption of NO ⅐ . One distinguishing feature of the present study is that Nox4 is thought to produce H 2 O 2 , a ROS species not associated with NO ⅐ consumption. Thus, our observations of enhanced NO ⅐ bioactivity with Nox4 may reflect the nature of the Nox product. Collectively, these 2 studies indicate that the phenotypic implications of ROS are contextual and depend on the Nox isoform involved.
Nox4 is known to produce H 2 O 2 , 14,15 and H 2 O 2 is known to activate Akt 41 and AMPK, 42 2 kinases important in eNOS regulation. [43] [44] [45] Thus, our data are consistent with the idea that Nox4-derived H 2 O 2 is responsible for promoting angiogenesis. With regard to the mechanism, we and others have demonstrated that Nox4 targeting to the endoplasmic reticulum facilitates protein tyrosine phosphatase 1B (PTP1B) inhibition. 24, 25 In mice lacking PTP1B, Akt activation is prolonged. 46 Because Nox4-mediated PTP1B inhibition enhances endothelial proliferation 24 and PTP1B inhibition stimulates VEGF-induced endothelial proliferation and angiogenesis, 47, 48 it is plausible that PTP1B inhibition is a mechanism for Nox4-mediated eNOS activation.
Endothelial Nox4 is likely not the only ROS-sensitive component of angiogenesis. In fact, previous observations have demonstrated that Nox stimulation of angiogenesis may involve other tissues such as the bone marrow 49 and other ROS-producing sources such as Nox2. 50 Although in our system we cannot rule out a role for the bone marrowderived cells, our work in cultured cells coupled with observations of capillary sprouting in intact vessels indicates that the bone marrow is not necessary for our observations. With regard to Nox2, we find that manipulation of Nox4 expression does not affect Nox2 expression (Figure 2A ), 24 and therefore we conclude that the effect seen here is due specifically to Nox4 manipulation in the endothelium. Figure 7 . Endothelial nitric oxide synthase (eNOS) is necessary for NADPH oxidase 4 (Nox4) stimulation of angiogenesis. Vascular endothelial cadherin transgenic (TG) Nox4 mice were bred onto the eNOS-null (eNOS Ϫ/Ϫ ) background to produce eNOS Ϫ/Ϫ Nox4 transgenic animals. A, Aortas were harvested from eNOS Ϫ/Ϫ and eNOS Ϫ/Ϫ Nox4 transgenic mice, and capillary sprouting was assessed in Matrigel over 7 days as in Figure 5A (nϭ3) . B, We subjected eNOS Ϫ/Ϫ and eNOS Ϫ/Ϫ Nox4 transgenic mice to hindlimb ischemia and monitored blood flow recovery as in Figure  5B (nϭ8 to 9 per group). C, Gastrocnemius muscle from control and ischemic limbs was harvested from animals treated as in B after 28 days, and capillary density was assessed by CD31 immunostaining as in Figure 5D (nϭ3 per group). D, Schematic of Nox4 adaptation to hypoxia. ROS indicates reactive oxygen species.
Collectively, the data presented here demonstrate that augmented endothelial Nox4 expression promotes angiogenesis and recovery from hypoxia through enhanced eNOS activation. Important questions remain such as the mechanism(s) whereby Nox4 is upregulated and the specific molecular targets between Nox4 and eNOS. Nevertheless, our findings support an adaptive role for Nox4 in response to tissue injury.
